A majority of disease patient groups continue to view the pharma industry favorably, an annual survey reports. (Shutterstock)
Horizon, Roche top list for pharma reputation among rare disease patient groups, survey finds
As rare disease drug research increases among large pharma companies, so do their reputations with rare disease patient groups. The latest survey in
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
